NASDAQ:STAA STAAR Surgical - STAA Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STAAR Surgical Please log in to your account or sign up in order to add this asset to your watchlist. $63.95 +1.54 (+2.47%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$62.74▼$64.1150-Day Range$55.39▼$79.3452-Week Range$46.35▼$112.27Volume413,306 shsAverage Volume762,239 shsMarket Capitalization$3.08 billionP/E Ratio81.99Dividend YieldN/APrice Target$82.20 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability STAAR Surgical MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside28.5% Upside$82.20 Price TargetShort InterestBearish10.55% of Shares Sold ShortDividend StrengthN/ASustainability-0.73Upright™ Environmental ScoreNews Sentiment0.49Based on 10 Articles This WeekInsider TradingSelling Shares$51,001 Sold Last QuarterProj. Earnings Growth104.48%From $0.67 to $1.37 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.96 out of 5 starsMedical Sector28th out of 1,004 stocksOphthalmic Goods Industry1st out of 7 stocks 4.4 Analyst's Opinion Consensus RatingSTAAR Surgical has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 8 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $82.20, STAAR Surgical has a forecasted upside of 28.5% from its current price of $63.95.Amount of Analyst CoverageSTAAR Surgical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted10.55% of the outstanding shares of STAAR Surgical have been sold short.Short Interest Ratio / Days to CoverSTAAR Surgical has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in STAAR Surgical has recently increased by 6.93%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSTAAR Surgical does not currently pay a dividend.Dividend GrowthSTAAR Surgical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSTAAR Surgical has received a 58.64% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Intraocular lenses" product. See details.Environmental SustainabilityThe Environmental Impact score for STAAR Surgical is -0.73. Previous Next 2.5 News and Social Media Coverage News SentimentSTAAR Surgical has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for STAAR Surgical this week, compared to 4 articles on an average week.Search InterestOnly 5 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.MarketBeat Follows5 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, STAAR Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $51,001.00 in company stock.Percentage Held by InsidersOnly 2.60% of the stock of STAAR Surgical is held by insiders.Percentage Held by Institutions97.55% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for STAAR Surgical are expected to grow by 104.48% in the coming year, from $0.67 to $1.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STAAR Surgical is 81.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.61.Price to Earnings Ratio vs. SectorThe P/E ratio of STAAR Surgical is 81.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 108.48.Price to Book Value per Share RatioSTAAR Surgical has a P/B Ratio of 9.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About STAAR Surgical (NASDAQ:STAA) StockSTAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.Read More Receive STAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address STAA Stock News HeadlinesMarch 31, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) Receives $83.89 Average Price Target from AnalystsMarch 30, 2023 | marketwatch.comOphthalmic Devices Market With New Statistical Report 2029March 31, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.March 30, 2023 | marketwatch.comSurgical Ophthalmology Market Share and Forecast till 2031March 29, 2023 | finance.yahoo.comStaar Surgical (STAA) Stock Sinks As Market Gains: What You Should KnowMarch 29, 2023 | markets.businessinsider.comSTAAR Surgical Appoints Warren Foust As COOMarch 29, 2023 | seekingalpha.comSTAAR Surgical hires Warren Foust as COOMarch 28, 2023 | marketwatch.comOphthalmic Devices Market Outlook and Forecast till 2030March 31, 2023 | Tradewins (Ad)Modern Day Options Trading For Beginners!These days it takes more than willpower to succeed on Wall Street and for new traders, even small mistakes can sink an account! With "Your Guide To Successful Options Trading" by expert Wendy Kirkland, you can avoid new trader pitfalls and learn to earn in this vicious market. March 24, 2023 | marketwatch.comOphthalmic Equipment Market Top Players By 2031March 24, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) Stock Price Down 3.2%March 24, 2023 | marketwatch.comCataract Surgery Devices Market Outlook By 2031March 23, 2023 | marketwatch.comIntraocular Lens (IOL) Material Market Size, Trends and Forecast 2028March 14, 2023 | msn.comSTAAR Surgical gains after reaffirming sales forecastMarch 14, 2023 | marketwatch.comMonofocal IOLs Market Application, Product, Sales and Forecast 2023-2028March 13, 2023 | finance.yahoo.comImplied Volatility Surging for STAAR Surgical (STAA) Stock OptionsMarch 10, 2023 | marketwatch.comOphthalmology Cataract Surgery Devices Market Application, Product, Sales and Forecast 2023-2028March 9, 2023 | finance.yahoo.comCalculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)March 8, 2023 | marketwatch.comOphthalmic Surgical Instruments Market Application, Product, Sales and Forecast 2023-2028March 1, 2023 | marketwatch.comOphthalmology Surgical Devices Market Industry Analysis, Estimates Size and Projections by 2029February 27, 2023 | marketwatch.comOphthalmic Surgical Devices Market 2023 | Size, Growth Rate, Key Players Share, And Industry Trends Analysis with Global Forecast 2023-2028February 24, 2023 | seekingalpha.comSTAAR Surgical Shines In Today's Uncertainties Due To Growing U.S. RevenueFebruary 24, 2023 | marketwatch.comOphthalmology Surgical Devices Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028February 23, 2023 | finance.yahoo.comSTAAR Surgical Full Year 2022 Earnings: EPS: US$0.81 (vs US$0.52 in FY 2021)February 23, 2023 | markets.businessinsider.comMizuho Securities Keeps Their Buy Rating on Staar Surgical (STAA)February 22, 2023 | benzinga.comSTAAR Surgical shares are trading lower after the company reported mixed Q4 financial results.February 22, 2023 | markets.businessinsider.comStephens Keeps Their Buy Rating on Staar Surgical (STAA)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive STAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address STAA Company Calendar Last Earnings11/03/2021Today3/31/2023Next Earnings (Estimated)5/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Ophthalmic goods Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:STAA CUSIP85231230 CIK718937 Webwww.staar.com Phone(626) 303-7902Fax626-303-2962Employees692Year Founded1982Price Target and Rating Average Stock Price Forecast$82.20 High Stock Price Forecast$125.00 Low Stock Price Forecast$60.00 Forecasted Upside/Downside+30.1%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.78 Trailing P/E Ratio81.01 Forward P/E Ratio94.31 P/E GrowthN/ANet Income$38.76 million Net Margins13.63% Pretax Margin16.02% Return on Equity12.91% Return on Assets10.32% Debt Debt-to-Equity RatioN/A Current Ratio6.03 Quick Ratio5.56 Sales & Book Value Annual Sales$284.39 million Price / Sales10.72 Cash Flow$0.91 per share Price / Cash Flow69.26 Book Value$6.89 per share Price / Book9.17Miscellaneous Outstanding Shares48,240,000Free Float46,982,000Market Cap$3.05 billion OptionableOptionable Beta1.23 Social Links Key ExecutivesThomas G. FrinziChairman, President & Chief Executive OfficerPatrick F. WilliamsChief Financial Officer & Vice PresidentKeith HollidayChief Technology OfficerScott D. BarnesChief Medical OfficerSamuel J. GestenSecretary & Chief Legal OfficerKey CompetitorsNational VisionNASDAQ:EYEWarby ParkerNYSE:WRBYBausch + LombNYSE:BLCOLife Time GroupNYSE:LTHVaxcyteNASDAQ:PCVXView All CompetitorsInsiders & InstitutionsMetropolitan Life Insurance Co. NYBought 184 shares on 3/31/2023Ownership: 0.006%Neo Ivy Capital ManagementBought 14,556 shares on 3/27/2023Ownership: 0.030%MetLife Investment Management LLCSold 509 shares on 3/23/2023Ownership: 0.113%Keith HollidaySold 823 sharesTotal: $51,001.31 ($61.97/share)Rockefeller Capital Management L.P.Bought 205 shares on 3/6/2023Ownership: 0.004%View All Insider TransactionsView All Institutional Transactions STAA Stock - Frequently Asked Questions Should I buy or sell STAAR Surgical stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" STAA shares. View STAA analyst ratings or view top-rated stocks. What is STAAR Surgical's stock price forecast for 2023? 10 brokers have issued 12-month price targets for STAAR Surgical's shares. Their STAA share price forecasts range from $60.00 to $125.00. On average, they expect the company's stock price to reach $82.20 in the next year. This suggests a possible upside of 30.1% from the stock's current price. View analysts price targets for STAA or view top-rated stocks among Wall Street analysts. How have STAA shares performed in 2023? STAAR Surgical's stock was trading at $48.54 at the start of the year. Since then, STAA shares have increased by 30.2% and is now trading at $63.19. View the best growth stocks for 2023 here. When is STAAR Surgical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023. View our STAA earnings forecast. How were STAAR Surgical's earnings last quarter? STAAR Surgical (NASDAQ:STAA) posted its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.01. The medical instruments supplier earned $58.35 million during the quarter, compared to analyst estimates of $57.70 million. STAAR Surgical had a net margin of 13.63% and a trailing twelve-month return on equity of 12.91%. During the same quarter in the previous year, the firm earned $0.14 earnings per share. What ETFs hold STAAR Surgical's stock? ETFs with the largest weight of STAAR Surgical (NASDAQ:STAA) stock in their portfolio include Janus Henderson Small Cap Growth Alpha ETF (JSML), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Pacer US Export Leaders ETF (PEXL), Janus Henderson US Sustainable Equity ETF (SSPX), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC) and AI Powered Equity ETF (AIEQ). What guidance has STAAR Surgical issued on next quarter's earnings? STAAR Surgical issued an update on its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $340.00 million-$340.00 million, compared to the consensus revenue estimate of $343.34 million. What is Caren Mason's approval rating as STAAR Surgical's CEO? 6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees. What other stocks do shareholders of STAAR Surgical own? Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU). What is STAAR Surgical's stock symbol? STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA." Who are STAAR Surgical's major shareholders? STAAR Surgical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (10.86%), Geneva Capital Management LLC (1.95%), E Fund Management Co. Ltd. (1.87%), Geode Capital Management LLC (1.87%), Principal Financial Group Inc. (1.42%) and Morgan Stanley (1.10%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten. View institutional ownership trends. How do I buy shares of STAAR Surgical? Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is STAAR Surgical's stock price today? One share of STAA stock can currently be purchased for approximately $63.19. How much money does STAAR Surgical make? STAAR Surgical (NASDAQ:STAA) has a market capitalization of $3.05 billion and generates $284.39 million in revenue each year. The medical instruments supplier earns $38.76 million in net income (profit) each year or $0.78 on an earnings per share basis. How many employees does STAAR Surgical have? The company employs 692 workers across the globe. Does STAAR Surgical have any subsidiaries? The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.Read More How can I contact STAAR Surgical? STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962. This page (NASDAQ:STAA) was last updated on 3/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.